1,1-dichloroethene decreases expression ISO RGD:733770 6480464 vinylidene chloride results in decreased expression of AKR1D1 mRNA CTD PMID:26682919 17beta-estradiol decreases expression ISO RGD:736637 6480464 Estradiol results in decreased expression of AKR1D1 mRNA CTD PMID:20106945 , PMID:21632981 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:736637 6480464 Dihydrotestosterone results in increased expression of AKR1D1 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 , PMID:31826744 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:733770 6480464 2 more ... CTD PMID:30294300 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:736637 6480464 2 more ... CTD PMID:31173147 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733770 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKR1D1 mRNA CTD PMID:19770486 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733770 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to AKR1D1 gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKR1D1 mRNA CTD PMID:20959002 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736637 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKR1D1 mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of AKR1D1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736637 6480464 Tetrachlorodibenzodioxin affects the expression of AKR1D1 mRNA CTD PMID:20106945 , PMID:22298810 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:736637 6480464 3 more ... CTD PMID:19692669 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3-chloropropane-1,2-diol affects expression EXP 6480464 alpha-Chlorohydrin analog affects the expression of AKR1D1 protein CTD PMID:26597043 3alpha-hydroxy-5beta-androstan-17-one multiple interactions ISO RGD:733770 6480464 [AKR1D1 protein alternative form results in increased metabolism of androstane-3 more ... CTD PMID:30928400 3alpha-hydroxy-5beta-androstan-17-one increases chemical synthesis ISO RGD:733770 6480464 AKR1D1 protein alternative form results in increased chemical synthesis of Etiocholanolone, AKR1D1 protein results in increased chemical synthesis of Etiocholanolone CTD PMID:30928400 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of AKR1D1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO RGD:733770 6480464 4, 4'-diaminodiphenylmethane results in increased expression of AKR1D1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases methylation ISO RGD:736637 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of AKR1D1 gene CTD PMID:31601247 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of AKR1D1 mRNA CTD PMID:36041667 5-Dihydrocortisol multiple interactions ISO RGD:733770 6480464 [AKR1D1 protein alternative form results in increased reduction of Hydrocortisone] which results in increased chemical synthesis of 5-dihydrocortisol CTD PMID:30928400 5-Dihydrocortisol increases chemical synthesis ISO RGD:733770 6480464 AKR1D1 protein alternative form results in increased chemical synthesis of 5-dihydrocortisol CTD PMID:30928400 5alpha-pregnane-3,20-dione increases chemical synthesis ISO RGD:736637 6480464 AKR1D1 protein results in increased chemical synthesis of 5-alpha-Dihydroprogesterone CTD PMID:18624455 5alpha-pregnane-3,20-dione multiple interactions ISO RGD:733770 6480464 [AKR1D1 protein alternative form results in increased reduction of Progesterone] which results in increased chemical synthesis of 5-alpha-Dihydroprogesterone CTD PMID:30928400 5alpha-pregnane-3,20-dione increases chemical synthesis ISO RGD:733770 6480464 AKR1D1 protein alternative form results in increased chemical synthesis of 5-alpha-Dihydroprogesterone CTD PMID:30928400 7alpha-hydroxycholest-4-en-3-one multiple interactions ISO RGD:736637 6480464 [AKR1D1 protein co-treated with NADP] results in increased reduction of 7 alpha-hydroxy-4-cholesten-3-one, AKR1D1 gene mutant form inhibits the reaction [AKR1D1 protein results in increased metabolism of 7 alpha-hydroxy-4-cholesten-3-one] CTD PMID:21185810 , PMID:25500266 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of AKR1D1 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:736637 6480464 Aflatoxin B1 affects the expression of AKR1D1 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:736637 6480464 Aflatoxin B1 results in decreased methylation of AKR1D1 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:736637 6480464 Aflatoxin B1 results in decreased expression of AKR1D1 mRNA CTD PMID:21632981 more ... aflatoxin B1 decreases expression ISO RGD:733770 6480464 Aflatoxin B1 results in decreased expression of AKR1D1 mRNA CTD PMID:19770486 Aflatoxin B2 alpha decreases methylation ISO RGD:736637 6480464 aflatoxin B2 results in decreased methylation of AKR1D1 intron CTD PMID:30157460 aldosterone multiple interactions ISO RGD:736637 6480464 [AKR1D1 protein co-treated with NADP] results in increased reduction of Aldosterone CTD PMID:25500266 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AKR1D1 mRNA CTD PMID:16483693 androst-4-ene-3,17-dione increases reduction ISO RGD:736637 6480464 AKR1D1 protein results in increased reduction of Androstenedione CTD PMID:30928400 androst-4-ene-3,17-dione multiple interactions ISO RGD:733770 6480464 [AKR1D1 protein alternative form results in increased reduction of Androstenedione] which results in increased chemical synthesis of androstane-3 more ... CTD PMID:30928400 androst-4-ene-3,17-dione increases reduction ISO RGD:733770 6480464 AKR1D1 protein alternative form results in increased reduction of Androstenedione, AKR1D1 protein results in increased reduction of Androstenedione CTD PMID:30928400 androstane-3,17-dione increases metabolic processing ISO RGD:733770 6480464 AKR1D1 protein alternative form results in increased metabolism of androstane-3 more ... CTD PMID:30928400 androstane-3,17-dione increases chemical synthesis ISO RGD:733770 6480464 AKR1D1 protein alternative form results in increased chemical synthesis of androstane-3 more ... CTD PMID:30928400 androstane-3,17-dione multiple interactions ISO RGD:733770 6480464 [AKR1D1 protein alternative form results in increased metabolism of androstane-3 more ... CTD PMID:30928400 atazanavir sulfate multiple interactions ISO RGD:736637 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of AKR1D1 mRNA CTD PMID:33819548 azathioprine decreases expression ISO RGD:736637 6480464 Azathioprine results in decreased expression of AKR1D1 mRNA CTD PMID:22623647 benzo[a]pyrene affects expression ISO RGD:736637 6480464 Benzo(a)pyrene affects the expression of AKR1D1 mRNA CTD PMID:20106945 benzo[a]pyrene affects methylation ISO RGD:736637 6480464 Benzo(a)pyrene affects the methylation of AKR1D1 intron, Benzo(a)pyrene affects the methylation of AKR1D1 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:736637 6480464 Benzo(a)pyrene results in decreased expression of AKR1D1 mRNA CTD PMID:21632981 more ... benzo[a]pyrene decreases expression ISO RGD:733770 6480464 Benzo(a)pyrene results in decreased expression of AKR1D1 mRNA CTD PMID:19770486 benzo[e]pyrene decreases methylation ISO RGD:736637 6480464 benzo(e)pyrene results in decreased methylation of AKR1D1 intron CTD PMID:30157460 beta-naphthoflavone decreases expression ISO RGD:736637 6480464 beta-Naphthoflavone results in decreased expression of AKR1D1 mRNA CTD PMID:19737606 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AKR1D1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of AKR1D1 mRNA CTD PMID:36041667 bisphenol A decreases methylation ISO RGD:736637 6480464 bisphenol A results in decreased methylation of AKR1D1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:733770 6480464 bisphenol A results in increased expression of AKR1D1 mRNA CTD PMID:30245210 bisphenol A affects expression ISO RGD:736637 6480464 bisphenol A affects the expression of AKR1D1 mRNA CTD PMID:30903817 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of AKR1D1 mRNA CTD PMID:36041667 butan-1-ol multiple interactions ISO RGD:736637 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of AKR1D1 mRNA CTD PMID:29432896 cadmium atom increases expression ISO RGD:736637 6480464 Cadmium results in increased expression of AKR1D1 mRNA CTD PMID:21120746 carbon nanotube decreases expression ISO RGD:733770 6480464 Nanotubes more ... CTD PMID:25620056 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of AKR1D1 mRNA CTD PMID:18172885 chenodeoxycholic acid multiple interactions ISO RGD:736637 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of AKR1D1 mRNA more ... CTD PMID:33819548 chloropicrin increases expression ISO RGD:736637 6480464 chloropicrin results in increased expression of AKR1D1 mRNA CTD PMID:26352163 cholest-4-en-3-one multiple interactions ISO RGD:736637 6480464 [AKR1D1 protein co-treated with NADP] results in increased reduction of cholest-4-en-3-one CTD PMID:25500266 choline multiple interactions ISO RGD:733770 6480464 [Dietary Fats co-treated with Choline deficiency] results in decreased expression of AKR1D1 mRNA, PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in decreased expression of AKR1D1 mRNA] CTD PMID:29246445 cisplatin increases expression ISO RGD:736637 6480464 Cisplatin results in increased expression of AKR1D1 mRNA CTD PMID:27392435 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of AKR1D1 mRNA CTD PMID:24386269 cocaine affects expression EXP 6480464 Cocaine affects the expression of AKR1D1 mRNA CTD PMID:20187946 copper(II) sulfate decreases expression ISO RGD:736637 6480464 Copper Sulfate results in decreased expression of AKR1D1 mRNA CTD PMID:19549813 corticosterone multiple interactions ISO RGD:736637 6480464 [AKR1D1 protein co-treated with NADP] results in increased reduction of Corticosterone CTD PMID:25500266 cortisol increases reduction ISO RGD:736637 6480464 AKR1D1 protein results in increased reduction of Hydrocortisone CTD PMID:30928400 cortisol increases reduction ISO RGD:733770 6480464 AKR1D1 protein alternative form results in increased reduction of Hydrocortisone, AKR1D1 protein results in increased reduction of Hydrocortisone CTD PMID:30928400 cortisol multiple interactions ISO RGD:733770 6480464 [AKR1D1 protein alternative form results in increased reduction of Hydrocortisone] which results in increased chemical synthesis of 5-dihydrocortisol CTD PMID:30928400 cortisone multiple interactions ISO RGD:736637 6480464 [AKR1D1 protein co-treated with NADP] results in increased reduction of Cortisone CTD PMID:25500266 coumarin affects expression EXP 6480464 coumarin affects the expression of AKR1D1 mRNA CTD PMID:16963487 cyclosporin A decreases expression ISO RGD:733770 6480464 Cyclosporine results in decreased expression of AKR1D1 mRNA CTD PMID:23830897 cyclosporin A multiple interactions ISO RGD:736637 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of AKR1D1 mRNA CTD PMID:33819548 cyclosporin A decreases expression ISO RGD:736637 6480464 Cyclosporine results in decreased expression of AKR1D1 mRNA CTD PMID:20106945 more ... decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of AKR1D1 mRNA CTD PMID:23914054 deoxycholic acid multiple interactions ISO RGD:736637 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of AKR1D1 mRNA more ... CTD PMID:33819548 dicrotophos decreases expression ISO RGD:736637 6480464 dicrotophos results in decreased expression of AKR1D1 mRNA CTD PMID:28302478 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of AKR1D1 mRNA CTD PMID:29391264 ethanol increases expression ISO RGD:733770 6480464 Ethanol results in increased expression of AKR1D1 mRNA CTD PMID:19167417 ethyl methanesulfonate increases expression ISO RGD:736637 6480464 Ethyl Methanesulfonate results in increased expression of AKR1D1 mRNA CTD PMID:23649840 flutamide increases expression EXP 6480464 Flutamide results in increased expression of AKR1D1 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of AKR1D1 mRNA CTD PMID:24793618 formaldehyde increases expression ISO RGD:736637 6480464 Formaldehyde results in increased expression of AKR1D1 mRNA CTD PMID:23649840 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of AKR1D1 mRNA CTD PMID:18172885 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of AKR1D1 mRNA CTD PMID:15345336 glycochenodeoxycholic acid multiple interactions ISO RGD:736637 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of AKR1D1 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO RGD:736637 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of AKR1D1 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:736637 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of AKR1D1 mRNA more ... CTD PMID:33819548 iodide salt increases expression EXP 6480464 Iodides deficiency results in increased expression of AKR1D1 protein CTD PMID:26795019 ivermectin decreases expression ISO RGD:736637 6480464 Ivermectin results in decreased expression of AKR1D1 protein CTD PMID:32959892 Lasiocarpine decreases expression ISO RGD:736637 6480464 lasiocarpine results in decreased expression of AKR1D1 mRNA CTD PMID:32234424 limonene decreases expression EXP 6480464 limonene results in decreased expression of AKR1D1 mRNA CTD PMID:12815608 lipopolysaccharide multiple interactions ISO RGD:736637 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of AKR1D1 mRNA CTD PMID:35811015 metacetamol decreases expression ISO RGD:733770 6480464 3-hydroxyacetanilide results in decreased expression of AKR1D1 mRNA CTD PMID:18544908 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of AKR1D1 mRNA CTD PMID:30467583 methapyrilene decreases methylation ISO RGD:736637 6480464 Methapyrilene results in decreased methylation of AKR1D1 intron CTD PMID:30157460 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of AKR1D1 protein CTD PMID:30467583 methyl methanesulfonate increases expression ISO RGD:736637 6480464 Methyl Methanesulfonate results in increased expression of AKR1D1 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:736637 6480464 methylmercuric chloride results in decreased expression of AKR1D1 mRNA CTD PMID:23179753 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of AKR1D1 mRNA CTD PMID:21515302 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of AKR1D1 mRNA CTD PMID:20360939 NADP zwitterion multiple interactions ISO RGD:736637 6480464 [AKR1D1 protein co-treated with NADP] results in increased reduction of 7 alpha-hydroxy-4-cholesten-3-one more ... CTD PMID:25500266 NADP(+) multiple interactions ISO RGD:736637 6480464 [AKR1D1 protein co-treated with NADP] results in increased reduction of 7 alpha-hydroxy-4-cholesten-3-one more ... CTD PMID:25500266 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of AKR1D1 mRNA CTD PMID:24136188 nefazodone multiple interactions ISO RGD:736637 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of AKR1D1 mRNA CTD PMID:33819548 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of AKR1D1 mRNA CTD PMID:22110744 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of AKR1D1 mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO RGD:736637 6480464 methyleugenol results in decreased expression of AKR1D1 mRNA CTD PMID:32234424 obeticholic acid decreases expression ISO RGD:736637 6480464 obeticholic acid results in decreased expression of AKR1D1 mRNA CTD PMID:27939613 paracetamol affects expression ISO RGD:733770 6480464 Acetaminophen affects the expression of AKR1D1 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:736637 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of AKR1D1 mRNA CTD PMID:33819548 paracetamol decreases expression ISO RGD:736637 6480464 Acetaminophen results in decreased expression of AKR1D1 mRNA CTD PMID:29067470 paracetamol multiple interactions ISO RGD:733770 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of AKR1D1 mRNA] CTD PMID:29246445 paracetamol decreases expression ISO RGD:733770 6480464 Acetaminophen results in decreased expression of AKR1D1 mRNA CTD PMID:18544908 , PMID:29246445 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:733770 6480464 perfluorooctane sulfonic acid results in decreased expression of AKR1D1 mRNA CTD PMID:19429403 perfluorooctanoic acid decreases expression ISO RGD:733770 6480464 perfluorooctanoic acid results in decreased expression of AKR1D1 mRNA CTD PMID:17681415 , PMID:19429403 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of AKR1D1 mRNA CTD PMID:19162173 phenobarbital increases expression ISO RGD:733770 6480464 Phenobarbital results in increased expression of AKR1D1 mRNA CTD PMID:19270015 phenobarbital affects expression ISO RGD:733770 6480464 Phenobarbital affects the expression of AKR1D1 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:736637 6480464 Phenobarbital results in increased expression of AKR1D1 mRNA CTD PMID:19084549 pirinixic acid decreases expression ISO RGD:733770 6480464 pirinixic acid results in decreased expression of AKR1D1 mRNA CTD PMID:20813756 pirinixic acid multiple interactions ISO RGD:733770 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of AKR1D1 mRNA CTD PMID:19710929 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:733770 6480464 Pregnenolone Carbonitrile results in increased expression of AKR1D1 mRNA CTD PMID:28903501 progesterone increases reduction ISO RGD:736637 6480464 AKR1D1 protein results in increased reduction of Progesterone CTD PMID:18624455 progesterone increases reduction ISO RGD:733770 6480464 AKR1D1 protein alternative form results in increased reduction of Progesterone, AKR1D1 protein results in increased reduction of Progesterone CTD PMID:30928400 progesterone multiple interactions ISO RGD:733770 6480464 [AKR1D1 protein alternative form results in increased reduction of Progesterone] which results in increased chemical synthesis of 5-alpha-Dihydroprogesterone CTD PMID:30928400 propiconazole increases expression ISO RGD:733770 6480464 propiconazole results in increased expression of AKR1D1 mRNA CTD PMID:21278054 Propiverine affects binding EXP 6480464 propiverine binds to AKR1D1 protein CTD PMID:29273565 quercetin decreases expression ISO RGD:736637 6480464 Quercetin results in decreased expression of AKR1D1 mRNA CTD PMID:21632981 rotenone decreases expression ISO RGD:736637 6480464 Rotenone results in decreased expression of AKR1D1 mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:736637 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of AKR1D1 mRNA CTD PMID:35811015 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of AKR1D1 mRNA CTD PMID:25055962 sodium arsenite decreases expression ISO RGD:736637 6480464 sodium arsenite results in decreased expression of AKR1D1 mRNA CTD PMID:29301061 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of AKR1D1 protein CTD PMID:29459688 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of AKR1D1 mRNA CTD PMID:22110744 Sunset Yellow FCF multiple interactions ISO RGD:736637 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of AKR1D1 mRNA CTD PMID:33819548 tartrazine multiple interactions ISO RGD:736637 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR1D1 mRNA CTD PMID:33819548 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of AKR1D1 mRNA CTD PMID:15885361 testosterone decreases expression ISO RGD:733770 6480464 Testosterone results in decreased expression of AKR1D1 mRNA CTD PMID:21669218 testosterone multiple interactions ISO RGD:736637 6480464 [AKR1D1 protein co-treated with NADP] results in increased reduction of Testosterone, AKR1D1 gene mutant form inhibits the reaction [AKR1D1 protein results in increased metabolism of Testosterone] CTD PMID:21185810 , PMID:25500266 tetrachloromethane decreases expression ISO RGD:733770 6480464 Carbon Tetrachloride results in decreased expression of AKR1D1 mRNA CTD PMID:27339419 , PMID:31919559 tetracycline increases expression ISO RGD:733770 6480464 Tetracycline results in increased expression of AKR1D1 mRNA CTD PMID:16917069 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of AKR1D1 mRNA CTD PMID:26222700 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of AKR1D1 mRNA CTD PMID:34492290 tolcapone affects binding EXP 6480464 tolcapone binds to AKR1D1 protein CTD PMID:19783845 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of AKR1D1 mRNA, troglitazone results in increased expression of AKR1D1 protein CTD PMID:21315101 , PMID:21515302 urethane decreases expression ISO RGD:736637 6480464 Urethane results in decreased expression of AKR1D1 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:736637 6480464 Valproic Acid results in decreased methylation of AKR1D1 gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of AKR1D1 mRNA CTD PMID:35594946 valproic acid decreases expression ISO RGD:736637 6480464 Valproic Acid results in decreased expression of AKR1D1 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid affects expression ISO RGD:736637 6480464 Valproic Acid affects the expression of AKR1D1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:736637 6480464 Valproic Acid results in increased expression of AKR1D1 mRNA CTD PMID:29154799 vancomycin increases expression ISO RGD:733770 6480464 Vancomycin results in increased expression of AKR1D1 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of AKR1D1 mRNA CTD PMID:22615374 XL147 multiple interactions ISO RGD:733770 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of AKR1D1 mRNA CTD PMID:27935865